Select Page

Company to buy

  • Size: small and medium-sized business
  • Revenue: 2-40 M EUR
  • Location of the target company: Europe and US.
  • Reason for acquisition: The company wants a sterile manufacturing, Filling, Packaging and distribution to launch a new project.
  • #CFIE PHB066

Overview of this buyer for a pharmacovigilance supplier Europe unit wanted

This buyer is looking for a new acquisition worldwide. The company is interested to acquire pharmaceutical sterile manufacturing or filling to ramp up production capacity for production of new products. The company should have a sterile area with utilities, that is what the buyer is specifically looking for.

Profile (strategy) of pharmaceutical manufacturing buyer

A company with more than 500 employees with a presence in more than 19 countries. Focusing on immunology business, the firm research and development allergy treatments. They have presence in Europe and US market and their products include both injectable and sublingual (oral) vaccines for grass, tree and house dust mite. Besides that, there are other vaccines in pre-clinical development. The company holds international manufacturing approvals from regulatory agencies the United States Food and Drug Administration and the Europe Union. Their products are already marketed in the USA, Germany, Netherlands, Austria, UK, Spain, Italy, Switzerland and others.

The company’s main pharma products are:

  • Pollinex
  • Pollinex Quattro
  • Oralvac
  • Acarovac Plus
  • Venomil
Subscribe as an interested seller
Contact us to get details about this buyer for sterile pharmaceutical manufacturer in europe

Activities and products of the target pharmaceutical manufacturing unit

The buyer is now looking for a company with products that provide sterile manufacturing or filling.

The goal of the buyer is to acquire a profitable manufacturing pharma company with EBITDA in the range of 1 – 5 million euro.

Highlights of the pharmaceutical manufacturing buyer

  • A specialist allergy treatment company with a good M&A activities.
  • Presence in more than 19 countries including EU and the USA.
  • Company’s products include both injectable and sublingual (oral) vaccines for grass, tree and house dust mite.

More information on this buyer for sterile pharmaceutical manufacturer in Europe

Please get in touch if you are interested in learning more about this buyer for sterile pharmaceutical manufacturer in Europe. For more pharma companies for sale please visit the section pharma companies for sale. For other pharma buyers, please visit the section pharma companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.

Subscribe as a seller for this Pharma buyer

en_GBEnglish (UK)